Miromatrix Medical
MIRO | NASDAQ
$3.39
+$0.02 (+0.59%)
At close: Dec 12, 2023, 04:00 PM ET
Miromatrix Medical Company Profile
Company profile explainedCompany Profile
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.
Key Executives
| Name | Position |
|---|---|
| James Douglas | Chief Financial Officer & Secretary |
Miromatrix Medical
| Country | United States |
| IPO Date | Jun 24, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Jeffrey James Ross |
Contact Details
6455 Flying Cloud Drive Eden Prairie,
Minnesota 55344 United States
Stock Details
| Ticker Symbol | MIRO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001527096 |
| CUSIP Number | 60471P108 |
| ISIN Number | US60471P1084 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove MIRO